Filana Therapeutics (FLNA)

• Market cap: $43.5M
• 1 day: 1.07%
• 5 days: -12.58%
• 1 month: -26.2%
• 3 months: -42.28%
• 6 months: -57.53%
• Year to date: -56.92%
• 1 year: -62.17%
• 5 years: -99.29%
• 10 years: -95.25%
• Sector: Healthcare
• Industry: Biotechnology

About: Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Employees: 20